In Lactobio we focus on new microbial solutions against pathogenic and resistant bacteria. Our vision is to create a leading biotech company based on our own research.
The products are based on our own research into new, probiotic bacteria strains as well as a PhD collaboration with Bispebjerg Hospital’s dermatological department on skin problems related to Staphylococcus aureus.
Lactobio has built a proprietary discovery and screening platform where our team of microbiologists, biotechnologists and biochemists identify, select and grow the best probiotic strains to target microbiome dysfunctions associated with specific diseases.
We develop cosmeceuticals, dietary supplements and live biotherapeutic products.
Søren Kjærulff, Founder & Chief Executive Officer
Søren Kjærulff is the CEO of Lactobio and also a co-founder of Fermbiotics ApS. Formerly, he was Senior Director of Biopharma R&D at Novozymes AS, where he was responsible for leading biology research in anti-infection and anti-inflammation.
He holds Ph.D. in molecular biology from University of Copenhagen and is the author of several peer-reviewed papers and several granted patents.
Charlotte Vedel, Founder & Chief Operating Officer
Charlotte Vedel is the COO of Lactobio and former CTO of Novo Nordisk Foundation Center for Biosustainability. Formerly Vice President of IP, DuPont Nutrition & Health and longterm experience as R&D manager and scientist in probiotics and antimicrobial compounds.
Ph.D. in microbiology from the Danish Technical University and author of several peer-reviewed papers and inventor of several granted patents.